OrbiMed Israel BioFund GP Limited Partnership

Average Profitability
<0.0001%
Insider Buys Quantity
9
Insider Buys Sum
$284,439.00
Insider Sells Quantity
1
Insider Sells Sum
$9,279.93

Insider Activity of OrbiMed Israel BioFund GP Limited Partnership

According to the SEC Form 4 filings, OrbiMed Israel BioFund GP Limited Partnership, being in a position of

  1. 10 percent owner at BiomX Inc.,
    оver the last 12 months, has bought 0 shares, and sold 24344 shares for $9,280,
    over all time since 2019-12-05, has bought 375327 shares for $284,439, and sold 24344 shares for $9,280.

The largest purchase of all time was on 2023-02-27 and amounted to 348000 shares of BiomX Inc. for $85,260.

The largest sale of all time was on 2024-05-15 and amounted to 24344 shares of BiomX Inc. for $9,280.

Biography of OrbiMed Israel BioFund GP Limited Partnership

No biography is available at this moment.

2024-05-15SaleBiomX Inc.
PHGE
10 percent owner
24,344
0.0486%
$0.38$9,280-60.55%
2024-03-15PurchaseBiomX Inc.
PHGE
10 percent owner
4,327
–
$0$0-38.11%
2023-02-27PurchaseBiomX Inc.
PHGE
10 percent owner
348,000
0.7935%
$0.24$85,260-12.5%
2019-12-19PurchaseBiomX Inc.
PHGE
director, 10 percent owner
3,500
0.0555%
$8.90$31,150-39%
2019-12-18PurchaseBiomX Inc.
PHGE
director, 10 percent owner
500
0.0089%
$8.93$4,465-31.69%
2019-12-11PurchaseBiomX Inc.
PHGE
director, 10 percent owner
5,400
0.0956%
$8.92$48,168-31.77%
2019-12-10PurchaseBiomX Inc.
PHGE
director, 10 percent owner
3,400
0.0603%
$8.75$29,750-30.3%
2019-12-09PurchaseBiomX Inc.
PHGE
director, 10 percent owner
6,000
0.1072%
$8.68$52,080-29.25%
2019-12-06PurchaseBiomX Inc.
PHGE
director, 10 percent owner
800
0.0134%
$8.00$6,400-27.92%
2019-12-05PurchaseBiomX Inc.
PHGE
director, 10 percent owner
3,400
0.0605%
$7.99$27,166-23.38%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.